FibroGen cuts jobs as it weighs anemia dr-g's future in US
FibroGen is cutting jobs and restructuring as it struggles to get an anemia pill back on track in the U.S. after a major regulatory blow.
https://www.biopharmadive.com/news/fibrogen-layoffs-roxadustat-fda-meeting/609825/